What should we do about student use of cognitive enhancers? An analysis of current evidence

Neuropharmacology

Volumn 64, Issue , 2013, Pages 588-595

  Ragan, C Ian ^a   Bard, Imre ^b   Singh, Ilina ^b  

^a CIR Consulting Ltd ^*  (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Amphetamine; Caffeine; Cognition; Methylphenidate; Modafinil; Student

Indexed keywords

ADRAFINIL; AMPHETAMINE; ARMODAFINIL; DEXAMPHETAMINE; LISDEXAMFETAMINE; METHYLPHENIDATE; MODAFINIL; PLACEBO; PSYCHOSTIMULANT AGENT;

ACADEMIC ACHIEVEMENT; ATTENTION DEFICIT DISORDER; COGNITION; DRUG ABUSE; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG USE; HEALTH CARE POLICY; HUMAN; LONG TERM MEMORY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEMORY CONSOLIDATION; MOTIVATION; OFF LABEL DRUG USE; ONLINE SYSTEM; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECREATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STUDENT; TASK PERFORMANCE; UNITED STATES; WAKEFULNESS; WORKING MEMORY;

COGNITION; DIETARY SUPPLEMENTS; DRUG-SEEKING BEHAVIOR; EDUCATION; GUIDELINES AS TOPIC; HUMANS; MEMORY, SHORT-TERM; NEUROPHARMACOLOGY; NONPRESCRIPTION DRUGS; NOOTROPIC AGENTS; PERFORMANCE-ENHANCING SUBSTANCES; PROFESSIONAL ROLE; STREET DRUGS; STUDENTS; TEST TAKING SKILLS;

EID: 84866346066     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.016     Document Type: Review

References (68)

1. Academy of Medical Sciences Brain Science, Addiction and Drugs 2008 http://www.acmedsci.ac.uk/p99puid126.html
2. L.E. Arnold Methylphenidate vs. amphetamine: comparative review J. Att. Dis. 3 4 2000 200 211
3. A.M. Arria, K.M. Caldeira, K.E. O'Grady, K.B. Vincent, E.P. Johnson, and E.D. Wish Non-medical use of prescription stimulants among college students: associations with attention-Deficit-Hyperactivity disorder and polydrug use Pharmacotherapy 28 2 2008 156 169
4. J. Arrowsmith A decade of change Nat. Rev. Drug Discov. 11 2012 17 18
5. Q. Babcock, and T. Byrne Student perceptions of methylphenidate abuse at a public liberal arts college J. Am. Coll. Health 49 2000 143 145
6. M.J. Baggott, E. Erowid, F. Erowid, and J.E. Mendelson Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-based survey of 500 users Clin. Pharmacol. Ther. 75 2004 72
7. N. Bostrom, and A. Sandberg Cognitive enhancement: methods, ethics, regulatory challenges Sci. Eng. Ethics 15 3 2009 311 341
8. British Medical Association Boosting Your Brainpower: Ethical Aspects of Cognitive Enhancements 2007 http://www.bma.org.uk/images/Boosting-brainpower- tcm41-147266.pdf
9. CBS 60 Minutes Boosting Brain Power 2010 http://www.cbsnews.com/video/ watch/?id=6430949n&tag=api
10. C. Coenen, M. Schuijff, M. Smits, P. Klaasen, L. Hennen, M. Rader, and G. Wolbring Human Enhancement - STOA Report (IP/A/STOA/FWC/2005-28/SC35, 41 & 45) 2009 European Parliament Brussels
11. DAK Gesundheitsreport DAKForschung 2009 http://www.dak.de/content/ filesopen/Gesundheitsreport-2009.pdf
12. S. Davies, T. Lee, J. Ramsay, P.I. Dargan, and D.M. Wood Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances) Eur. J. Clin. Pharmacol. 68 4 2011 435 439
13. A. DeSantis, and A. Hane "Adderall is definitely not a drug": justifications for the illegal use of ADHD stimulants Subst. Use Misuse 45 1-2 2010 31 46
14. A. DeSantis, S.M. Noar, and E.M. Webb Speeding through the frat house: a qualitative exploration of non-medical ADHD stimulant use in fraternities J. Drug Educ. 40 2 2010 157 171
15. J. Dodgson, M. Spackmann, A. Pearman, and L. Phillips Multi-criteria Decision Analysis: a Manual 2000 Department of the Environment, Transport and the Regions London
16. D. Engber Bowling with brainwaves Slate 2006 http://www.slate.com/ articles/technology/gaming/2006/12/bowling-with-brain-waves.single.html
17. European Medicines Agency Questions and Answers on the Review of Medicines Containing Modafinil EMA/CHMP/460496/2010 2010
18. M.J. Farah, E. Parens, B. Sahakian, and P.R. Wolpe Neurocognitive enhancement: what can we do and what should we do? Nat. Rev. Neurosci. 5 5 2004 421 425
19. S. Faraone, J. Biederman, and C. Roe Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis J. Clin. Psychopharmacol. 22 5 2002 468 473
20. S. Faraone, T. Spencer, M. Aleardi, C. Pagano, and J. Biederman Meta-Analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder J. Clin. Psychopharmacol. 24 1 2004 24 29
21. K. Finke, C.M. Dodds, P. Bublak, R. Regenthal, F. Baumann, T. Manly, and U. Müller Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study Psychopharmacology 210 2010 317 329
22. K. Flower, L. Li, C.-Y.A. Chen, M.J. Baggott, G.P. Galloway, and J. Mendelson Efficacy, safety, and ethics of cosmetic neurology far from settled Clin. Pharmacol. Ther. 88 2010 461 463
23. A.G. Franke, C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, A. Hildt, and K. Lieb Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany Pharmacopsychiatry 43 2010 1 7
24. G. Gaskell, S. Stares, A. Allansdottir, N. Allum, P. Castro, Y. Esmer, C. Fischler, J. Jackson, N. Kronberger, J. Hampel, N. Mejlgaard, A. Quintanilha, A. Rammer, G. Revuelta, P. Stoneman, H. Torgersen, and W. Wagner Europeans and Biotechnology in 2010 2010 European Union Luxemburg
25. H. Greely, B. Sahakian, J. Harris, R. Kessler, M. Gazzinga, P. Campbell, and M. Farah Towards responsible use of cognitive enhancing drugs by the healthy Nature 456 2008 702 705
26. L. Greenhill, S. Kollins, H. Abikoff, J. McCracken, M. Riddle, J. Swanson, J. McGough, S. Wigal, T. Wigal, B. Vitiello, A. Skrobala, K. Posner, J. Ghuman, C. Cuningham, M. Davies, S. Chuang, and T. Cooper Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD J. Am. Acad. Child. Adolesc. Psychiatry 45 11 2006 1284 1293
27. A. Habibzadeh, M. Alizadeh, A. Malek, L. Maghbooli, M.M. Shoja, and K. Ghabili Illicit methylphenidate use among Iranian medical students: prevalence and knowledge Drug Des. Devel. Ther. 5 2011 71 76
28. K.M. Hall, M.M. Irwin, K.A. Bowman, W. Frankenberger, and D.C. Jewett Illicit use of prescribed stimulant medication among college students J. Am. Coll. Health 53 4 2005 167 174
29. D.J. Heal, S.C. Cheetham, and S.L. Smith The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety Neuropharmacology 57 2009 608 618
30. K. Holloway, and T. Bennett Prescription drug misuse among university staff and students: a survey of motives, nature and extent Drugs Educ. Prev. Policy 19 2012 137 144
31. Z. Huang, W.-M. Qu, N. Eguchi, J.-F. Chen, M.A. Schwarzschild, B.B. Fredholm, Y. Urade, and O. Hayaishi Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine Nat. Neurosci. 8 2005 858 859
32. T. Humle, and M. Friislund 'Study drugs' vinder frem på universiteter Information 2010 http://www.information.dk/236139
33. L. Iversen Speed, Ecstasy, Ritalin: the Science of Amphetamines 2008 Oxford University Press
34. R. Jones, K. Morris, and D. Nutt Cognition enhancers D. Nutt, T.W. Robbins, G.V. Stimson, M. Ince, A. Jackson, Drugs and the Future: Brain Science, Addiction and Society 2007 Academic Press 241 283
35. R.C. Kadosh, N. Levy, J. O'Shea, N. Shea, and J. Savulescu The neuroethics of non-invasive brain stimulation Curr. Biol. 2012 http://download.cell.com/images/edimages/CurrentBiology/homepage/curbio9329.pdf
36. D. Larriviere, M.A. Williams, M. Rizzo, and R.J. Bonnie Responding to requests from adult patients for neuroenhancements: guidance of the ethics, law and humanities committee Neurology 73 2009 1406 1412
37. N. Lennard One in Ten Takes Drugs to Study 2009 Varsity Student Newspaper. March 6 http://www.varsity.co.uk/news/1307
38. M.J. Millan, Y. Agid, M. Brune, E.T. Bullmore, C.S. Carter, N.S. Clayton, R. Connor, S. Davis, B. Deakin, R.J. DeRubeis, B. Dubois, M.A. Geyer, G.M. Goodwin, P. Gorwood, T.M. Jay, M. Joels, I.M. Mansuy, A. Meyer-Lindenberg, D. Murphy, E. Rolls, B. Saletu, M. Spedding, J. Sweeney, M. Whittington, and L.J. Young Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy Nat. Rev. Drug Discov. 11 2012 141 168
39. U. Müller, N. Steffenhagen, R. Regenthal, and P. Bublak Effects of modafinil on working memory processes in humans Psychopharmacology 177 2004 161 169
40. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 2008 1477 1502
41. E. Murguia, M. Tackett-Gibson, A. Lessem, A. Crispino, S.N. Gatson, S. Halbert, J. Kotarba, and R. Willard Real Drugs in a Virtual World: Drug Discourse and Community On-line 2007 Lexington Books Lanham
42. R.C. Nadler, and P.B. Reiner A call for data to inform discussion on cognitive enhancement BioSocieties 5 2010 481 487
43. C. Nixey Are 'smart Drugs' Safe for Students? 2010 http://www.guardian. co.uk/education/2010/apr/06/students-drugs-modafinil-ritalin
44. D.J. Nutt, L.A. King, W. Saulsbury, and C. Blakemore Development of a rational scale to assess the harm of drugs of potential misuse Lancet 369 2007 1047 1053
45. D.J. Nutt, L.A. King, and on behalf of the Independent Scientific Committee on Drugs Drug harms in the UK: a multicriteria decision analysis Lancet 376 2010 1558 1565
46. S.M. Outram The use of methylphenidate among students: the future of enhancement? J. Med. Ethics 36 2010 198 202
47. A.L. Peterkin, C.C. Crone, M.J. Sheridan, and T.N. Wise Cognitive performance enhancement: misuse or self-treatment? J. Att. Dis. 15 2010 263 268
48. B.B. Quednow Ethics of neuroenhancement: a phantom debate BioSocieties 5 2010 153 156
49. I. Ragan Drug futures 2025? Perspective of the pharmaceutical industry D. Nutt, T.W. Robbins, G.V. Stimson, M. Ince, A. Jackson, Drugs and the Future: Brain Science, Addiction and Society 2007 Academic Press 507 533
50. D.L. Rainer, A.D. Anastopoulos, E.J. Costello, R.H. Hoyle, S.E. McCabe, and H.S. Swartzwelder Motives and perceived consequences of non-medical ADHD medication use by college students: are students treating themselves for attention problems? J. Atten. Disord. 13 3 2009 259 270
51. D. Repantis, P. Schlattmann, O. Laisney, and I. Heuser Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review Pharmacol. Res. 62 2010 187 206
52. J.A. Ribeiro, and A.M. Sebastião Caffeine and adenosine J. Alzheimers Dis. 20 2010 S3 S15
53. T.W. Robbins Neuropsychopharmacology Brain Waves Module 1: Neuroscience, Society and Policy 2011 The Royal Society http://royalsociety.org/policy/ projects/brain-waves/society-policy/
54. S. Rolles, and F. Measham Questioning the method and utility of ranking drug harms in drug policy Int. J. Drug Policy 22 4 2011 243 246
55. J. Rosiers, A. Hublet, J. Van Damme, L. Maes, and G. Van Hal In hogere sferen? Een onderzoek naar het middelengebruik bij Vlaamse studenten vol. 2 2010 Vereniging voor Alcohol-en andere Drugproblemen Brussel
56. Scheske, C.; Schnall, S.; The ethics of 'smart drugs': moral judgments about healthy people's use of cognitive-enhancing drugs. Basic Appl. Soc. Psycho.; in press.
57. S. Schleim Second thoughts on the prevalence of enhancement BioSocieties 5 2010 484 485
58. P. Seeman, H.C. Guan, and H. Hirbec Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil Synapse 63 2009 698 704
59. I. Singh, and K.J. Kelleher Neuroenhancement in young people: proposal for research, policy and clinical management Am. J. Bioeth. Neurosci. 1 1 2010 3 16
60. M.F. Smith, and M.J. Farah Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals Psychol. Bull. 137 5 2011 717 741
61. C. Sugden, C.R. Housden, R. Aggarwal, B.J. Sahakian, and A. Darzi Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: a randomized controlled trial Ann. Surg. 255 2 2012 222 227
62. M. Synofzik Ethically justified, clinically applicable criteria for physician decision-making in psychopharmacological enhancement Neuroethics 2 2009 89 102
63. Talbot, M.; 2009. http://www.guardian.co.uk/science/2009/sep/20/ neuroenhancers-us-brain-power-drugs.
64. C.J. Teter, S.E. McCabe, K. LaGrange, J.A. Cranford, and C.J. Boyd Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration Pharmacotherapy 10 2006 1501 1510
65. D.C. Turner, T.W. Robbins, L. Clark, A.R. Aron, J. Dowson, and B.J. Sahakian Cognitive enhancing effects of modafinil in healthy volunteers Psychopharmacology (Berl) 165 3 2002 260 269 Epub 2002 Nov 1
66. D.C. Turner, L. Clark, J. Dowson, T.W. Robbins, and B.J. Sahakian Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder Biol. Psychiatry 55 10 2004 1031 1040
67. P. Wax Just a click away: recreational drug web sites on the internet Pediatrics 109 6 2002 e96
68. D. Zolkowska, R. Jain, R.B. Rothman, J.S. Partilla, B.L. Roth, V. Setola, T.E. Prisinzano, and M.H. Baumann Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil J. Pharmacol. Exp. Ther. 329 2009 738 746